{"nctId":"NCT00702715","briefTitle":"Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)","startDateStruct":{"date":"2008-09-24","type":"ACTUAL"},"conditions":["Anesthesia"],"count":69,"armGroups":[{"label":"Participants with severe renal impairment","type":"EXPERIMENTAL","interventionNames":["Drug: sugammadex"]},{"label":"Participants with normal renal function","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: sugammadex"]}],"interventions":[{"name":"sugammadex","otherNames":["Org 25959"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* At least 18 years of age\n* ASA class 1-3\n* Creatinine clearance (CLcr) \\< 30 mL/min and no anticipated clinical\n\nindication for high flux hemodialysis during first 24 hours after\n\nsugammadex administration (for renally impaired group) or CLcr \\>= 80\n\nmL/min (for control group)\n\n-Scheduled for a surgical procedure under general anesthesia with propofol\n\nrequiring neuromuscular relaxation with the use of rocuronium\n\n* Scheduled for a surgical procedure in supine position\n* Written informed consent\n\nExclusion Criteria:\n\n\\- Subjects known or suspected to have neuromuscular disorders impairing\n\nneuromuscular blockade and/or significant hepatic dysfunction\n\n* Subjects scheduled for renal transplant surgery\n* Subjects known or suspected to have a (family) history of malignant\n\nhyperthermia\n\n-Subjects known or suspected to have an allergy to narcotics, muscle\n\nrelaxants or other medication used during general anesthesia\n\n* Subjects receiving fusidic acid, toremifene and/or flucloxacillin\n* Subjects who have already participated in a sugammadex trial\n* Subjects who have participated in another clinical trial, not pre-approved\n\nby the sponsor, within 30 days of entering into 19.4.328 (P05769)\n\n* Female subjects who are pregnant\n* Female subjects who are breast-feeding","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Time to Recovery of the T4/T1 Ratio to 0.9.","description":"Neuromuscular functioning was monitored by applying repetitive train of four (TOF) electrical stimulations to the ulnar nerve every 15 seconds and assessing twitch response at the adductor pollicis muscle. Nerve stimulation continued until the ratio of the magnitude of the fourth twitch (T4) to first twitch (T1) reached at least 0.9. The greater the T4/T1 ratio the greater the recovery from neuromuscular blockade, with a value of 1.0 representing full recovery.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"205","spread":null},{"groupId":"OG001","value":"112","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Recovery of the T4/T1 Ratio to 0.8","description":"Neuromuscular functioning was monitored by applying repetitive train of four (TOF) electrical stimulations to the ulnar nerve every 15 seconds and assessing twitch response at the adductor pollicis muscle. Nerve stimulation continued until the ratio of the magnitude of the fourth twitch (T4) to first twitch (T1) reached at least 0.9. The greater the T4/T1 ratio the greater the recovery from neuromuscular blockade, with a value of 1.0 representing full recovery.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"169","spread":null},{"groupId":"OG001","value":"90","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Recovery of T4/T1 Ratio to 0.7","description":"Neuromuscular functioning was monitored by applying repetitive train of four (TOF) electrical stimulations to the ulnar nerve every 15 seconds and assessing twitch response at the adductor pollicis muscle. Nerve stimulation continued until the ratio of the magnitude of the fourth twitch (T4) to first twitch (T1) reached at least 0.9. The greater the T4/T1 ratio the greater the recovery from neuromuscular blockade, with a value of 1.0 representing full recovery.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"144","spread":null},{"groupId":"OG001","value":"79","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":35},"commonTop":["Procedural pain","Procedural hypotension","Procedural nausea","Anaemia","Nausea"]}}}